Should I Buy GNTA? GNTA 2026 Analysis

Should You Buy Genenta Science SPA (GNTA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

1.170

1 Day change

-13.33%

52 Week Range

10.000

Analysis Updated At

2026/01/28

GNTA is not a good buy right now for a Beginner, long-term investor with $50k–$100k who is impatient and doesn’t want to wait for an optimal entry. The stock is in a clear bearish trend (SMA_200 > SMA_20 > SMA_5) and just experienced a sharp selloff (about -12% regular session plus additional weakness). With no news catalysts, no supportive options read, no proprietary buy signals today, and no usable financial snapshot to confirm improving fundamentals, the risk/reward is not attractive for an immediate long-term entry. Avoid buying now.

Technical Analysis

Price action is weak: the stock closed at 1.32 vs 1.54 prior close (-12.34%) and continued lower post-market (-2.21%), confirming heavy near-term selling pressure. Trend: Bearish moving average stack (SMA_200 > SMA_20 > SMA_5) indicates a downtrend across long-, mid-, and short-term timeframes. Momentum: MACD histogram is positive (0.0249) but contracting—this often suggests bullish momentum is fading rather than strengthening. RSI_6 at ~46.7 is neutral, so there’s no oversold reading to justify an “impatient buy-the-dip” entry. Levels: Pivot 1.439 is now overhead resistance; near support is S1 1.271 (then S2 1.167). With price at 1.32, it’s uncomfortably close to support—risk of another leg down remains. Upside levels to reclaim would be 1.439 first, then 1.607. Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

No news in the last week, so there are no clear event-driven catalysts. The pattern-based forecast provided suggests a modest probability skew to small gains over the next day/week/month, which could support a short-term bounce attempt if support holds. Hedge funds and insiders are reported as Neutral (no significant recent trend), reducing concern about aggressive distribution from those groups.

Neutral/Negative Catalysts

Sharp recent selloff (large down day and continued post-market weakness) while the longer-term trend remains bearish (SMA_200 > SMA_20 > SMA_5). No recent news catalysts to explain/stop the decline and no options sentiment data to confirm bullish positioning. Support is close (S1 1.271, S2 1.167), so downside continuation is plausible if 1.271 breaks. Also, no usable financial snapshot was provided, limiting the ability to confirm improving fundamentals for a long-term buy.

Financial Performance

Financial snapshot unavailable (data error: list index out of range), so the latest quarter and growth trends cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no observable recent trend in Wall Street ratings/targets to support a buy thesis. Net pros/cons view from analysts cannot be confirmed from the provided dataset.

1 Analyst Rating

Wall Street analysts forecast GNTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNTA is 7 USD with a low forecast of 7 USD and a high forecast of 7 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.350

Low

Averages

High